PDF herunterladen
Horm Metab Res 2015; 47(03): e9
DOI: 10.1055/a-1736-9074
Note of Concern

Note of Concern: DASH Diet, Insulin Resistance, and Serum hs-CRP in Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial

Z. Asemi
1   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
,
A. Esmaillzadeh
2   Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3   Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Note of Concern

DASH Diet, Insulin Resistance, and Serum hs-CRP in Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial

Asemi Z, Esmaillzadeh A. Horm Metab Res 2015; 47

DOI: 10.1055/s-0034-1376990

Since publication of this article, serious concerns have been raised about the integrity of the reported methods, results and analysis. Responses by the leading author and ethics committees have been unsatisfactory and inconclusive; we advise readers to interpret the information presented in the article with due caution.



Publikationsverlauf

Artikel online veröffentlicht:
28. Januar 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

Einführung zu:

DASH Diet, Insulin Resistance, and Serum hs-CRP in Polycystic Ovary Syndrome: A Randomized Controlled Clinical TrialHorm Metab Res 2015; 47(03): 232-238
DOI: 10.1055/s-0034-1376990